BackArcadia Biosciences Overview

Arcadia Biosciences Receivables

Arcadia Biosciences's receivables is $560K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$559000.00
↓ 55.78% YoYΔ $-705000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Arcadia Biosciences Receivables History

Loading

Arcadia Biosciences vs. peers: Receivables Comparison

Loading

Arcadia Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Arcadia Biosciences (RKDA) FAQ

As of the most recent data (June 2026), RKDA shows a receivables of $560K. That compares with $1.3M in the prior-year period — down 55.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RKDA's receivables is now $560K (was $1.3M) — a 55.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Arcadia Biosciences is outperforming or lagging.

Tracking RKDA's receivables over time shows whether Arcadia Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $560K That compares with $1.3M in the prior-year period — down 55.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Arcadia Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $560K) with ownership activity and broader fundamentals.

Arcadia Biosciences's receivables is $560K; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.